EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Tumor Whole-Genome Sequencing for Prediction of Venous Thromboembolism in Patients With Metastasized Solid Cancer

Frits I Mulder iD, Noori A M Guman iD, Job van Riet iD, Roos J van Geffen iD, Thijs F van Haaps iD, Vahram Hovsepjan iD, Hanneke W M van Laarhoven iD, Geert A Cirkel iD, Filip Y F L de Vos iD, Hans M Westgeest iD, Laurens V Beerepoot iD, Judith de Vos-Geelen iD und 12 weitere

Circulation: Genomic and Precision Medicine · 2026-06 · 19 (3)

DOI: 10.1161/circgen.124.005182 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Circulation: Genomic and Precision Medicine, 2026-06. Verfasst von Frits I Mulder und 23 weiteren Autor:innen. Beteiligte Einrichtung: Department of Vascular Medicine, Amsterdam UMC Location University of Amsterdam, the Netherlands (F.I.M., N.A.M.G., R.J.v.G., T.F.v.H., V.H., H.R.B.,…. Hauptthemen laut MEDLINE: Venous Thromboembolism, Neoplasms, Whole Genome Sequencing. Die Arbeit nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: International guidelines suggest prophylactic anticoagulation for patients with cancer at high risk of venous thromboembolism (VTE). Here, we evaluated whether tumor whole-genome sequencing data may improve the selection of high-risk patients. METHODS: In a pan-cancer cohort of 3087 patients, associations of candidate clinical predictors, the germline extended 297-single nucleotide polymorphism polygenic risk score, tumor mutational characteristics, and somatic tumor mutations with VTE were estimated by calculating hazard ratios (HRs). RESULTS: During 12-month follow-up, 237 (7.7%) developed VTE. The germline extended 297-single nucleotide polymorphism score was associated with VTE (HR per point increase, 2.11 [95% CI, 1.45–3.06]), as well as the total number of somatic structural variants (HR per 1000 increase, 1.21 [95% CI, 1.07–1.37]) and 129 somatic mutations (unadjusted P

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Venous ThromboembolismNeoplasmsWhole Genome SequencingHumansFemaleMalePolymorphism, Single NucleotideMiddle AgedGenetic Risk ScoreAgedNeoplasm MetastasisMutationGerm-Line Mutation

Stichwörter der Autor:innen

anticoagulantsgerm cellshumansmutationneoplasms

Autor:innen und Institutionen

  • Department of Vascular Medicine, Amsterdam UMC Location University of Amsterdam, the Netherlands (F.I.M., N.A.M.G., R.J.v.G., T.F.v.H., V.H., H.R.B., P.W.K., N.v.E.).
  • Amsterdam Cardiovascular Sciences, Pulmonary Hypertension and Thrombosis, the Netherlands (F.I.M., N.A.M.G., R.J.G., T.F.H., V.H., H.R.B., P.W.K., N.v.E.).
  • Department of Internal Medicine, Tergooi MC, Hilversum, the Netherlands (F.I.M., N.A.M.G., P.W.K., N.v.E.).
  • Department of Medical Oncology, Amsterdam UMC Location Vrije Universiteit Amsterdam, the Netherlands (F.I.M., H.W.M.v.L., M. Labots).
  • Division of AI in Oncology, German Cancer Research Ctr DKFZ, Heidelberg, Germany (J.v.R.).
  • Cancer Centre Amsterdam, Imaging & Biomarkers, the Netherlands (H.W.M.L., M. Labots).

ORCID-Profile: Frits I Mulder, Noori A M Guman, Job van Riet, Roos J van Geffen, Thijs F van Haaps, Vahram Hovsepjan, Hanneke W M van Laarhoven, Geert A Cirkel, Filip Y F L de Vos, Hans M Westgeest, Laurens V Beerepoot, Judith de Vos-Geelen, Mariette Labots, Paul Hamberg, Annelie J E Vulink, Maartje Los, Aeilko H Zwinderman, Debbie G J Robbrecht, Harry R Büller, Pieter W Kamphuisen, Bart Ferwerda, Neeltje Steeghs, Nick van Es

Zitieren

APA

Mulder, F. I., Guman, N. A. M., van Riet, J., van Geffen, R. J., van Haaps, T. F., Hovsepjan, V., van Laarhoven, H. W. M., Cirkel, G. A., de Vos, F. Y. F. L., Westgeest, H. M., Beerepoot, L. V., de Vos-Geelen, J., Labots, M., Hamberg, P., Vulink, A. J. E., Los, M., Zwinderman, A. H., Robbrecht, D. G. J., de Jonge, M. J. A., …, & van Es, N. (2026). Tumor Whole-Genome Sequencing for Prediction of Venous Thromboembolism in Patients With Metastasized Solid Cancer. Circulation: Genomic and Precision Medicine, 19(3). https://doi.org/10.1161/circgen.124.005182

Vancouver

Mulder FI, Guman NAM, van Riet J, van Geffen RJ, van Haaps TF, Hovsepjan V, et al. Tumor Whole-Genome Sequencing for Prediction of Venous Thromboembolism in Patients With Metastasized Solid Cancer. Circulation: Genomic and Precision Medicine. 2026;19(3). doi:10.1161/circgen.124.005182

BibTeX
@article{Mulder2026,
  author = {Mulder, Frits I and Guman, Noori A M and van Riet, Job and van Geffen, Roos J and van Haaps, Thijs F and Hovsepjan, Vahram and van Laarhoven, Hanneke W M and Cirkel, Geert A and de Vos, Filip Y F L and Westgeest, Hans M and Beerepoot, Laurens V and de Vos-Geelen, Judith and Labots, Mariette and Hamberg, Paul and Vulink, Annelie J E and Los, Maartje and Zwinderman, Aeilko H and Robbrecht, Debbie G J and de Jonge, Maja J A and Büller, Harry R and Kamphuisen, Pieter W and Ferwerda, Bart and Steeghs, Neeltje and van Es, Nick},
  title = {Tumor Whole-Genome Sequencing for Prediction of Venous Thromboembolism in Patients With Metastasized Solid Cancer},
  journal = {Circulation: Genomic and Precision Medicine},
  year = {2026},
  volume = {19},
  number = {3},
  doi = {10.1161/circgen.124.005182}
}
Kostenlos starten →